Human Immunoglobulin G [EPC]

Human Immunoglobulin G [EPC] was reported 21060 times

These side effects are most commonly reported by patients taking drugs of the Human Immunoglobulin G [EPC] class:

# Drug class Count
0 HEADACHE 7801
1 OFF LABEL USE 7493
2 FATIGUE 5849
3 SINUSITIS 4681
4 NAUSEA 4631
5 PYREXIA 4435
6 DRUG INEFFECTIVE 4164
7 PNEUMONIA 3797
8 DYSPNOEA 3785
9 MALAISE 3350
10 PAIN 3319
11 NO ADVERSE EVENT 3199
12 PRURITUS 3110
13 COVID-19 2978
14 CHILLS 2913
15 INFECTION 2813
16 VOMITING 2746
17 PRODUCT DOSE OMISSION ISSUE 2670
18 RASH 2669
19 DEATH 2564
20 DIARRHOEA 2561
21 INFUSION RELATED REACTION 2437
22 COUGH 2338
23 URTICARIA 2293
24 DIZZINESS 2194
25 URINARY TRACT INFECTION 2140
26 FALL 2121
27 NASOPHARYNGITIS 2103
28 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2061
29 ASTHENIA 2053
30 ARTHRALGIA 1957
31 INFUSION SITE PAIN 1939
32 ILLNESS 1887
33 WEIGHT DECREASED 1851
34 INFUSION SITE ERYTHEMA 1825
35 INFUSION SITE SWELLING 1818
36 BRONCHITIS 1817
37 BLOOD PRESSURE INCREASED 1815
38 PRODUCT USE IN UNAPPROVED INDICATION 1690
39 BACK PAIN 1669
40 CONDITION AGGRAVATED 1421
41 UPPER RESPIRATORY TRACT INFECTION 1419
42 MIGRAINE 1416
43 PAIN IN EXTREMITY 1413
44 INFLUENZA 1407
45 ERYTHEMA 1364
46 HYPERTENSION 1307
47 INSURANCE ISSUE 1283
48 HYPERSENSITIVITY 1282
49 WEIGHT INCREASED 1275
50 ABDOMINAL PAIN 1213
51 PRODUCT USE ISSUE 1203
52 TACHYCARDIA 1174
53 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1147
54 PERIPHERAL SWELLING 1112
55 FEELING ABNORMAL 1110
56 DECREASED APPETITE 1108
57 SEPSIS 1101
58 INFUSION SITE PRURITUS 1094
59 CHEST PAIN 1076
60 ASTHMA 1071
61 EAR INFECTION 1042
62 HYPOTENSION 1022
63 SWELLING 1013
64 CHEST DISCOMFORT 977
65 MYALGIA 968
66 INJECTION SITE ERYTHEMA 946
67 SOMNOLENCE 943
68 INJECTION SITE PAIN 925
69 RESPIRATORY TRACT INFECTION 914
70 INFLUENZA LIKE ILLNESS 895
71 DRUG HYPERSENSITIVITY 887
72 TREMOR 884
73 MENINGITIS ASEPTIC 867
74 CONTUSION 854
75 THERAPY INTERRUPTED 829
76 INJECTION SITE SWELLING 821
77 INFUSION SITE EXTRAVASATION 817
78 ANXIETY 816
79 ABDOMINAL PAIN UPPER 807
80 HOSPITALISATION 788
81 VIRAL INFECTION 787
82 ANAPHYLACTIC REACTION 781
83 INCORRECT DOSE ADMINISTERED 772
84 INSOMNIA 758
85 MUSCLE SPASMS 750
86 MUSCULAR WEAKNESS 750
87 OROPHARYNGEAL PAIN 741
88 INTENTIONAL PRODUCT USE ISSUE 734
89 ANAEMIA 720
90 GASTROINTESTINAL DISORDER 719
91 INFUSION SITE BRUISING 712
92 ABDOMINAL DISTENSION 710
93 OXYGEN SATURATION DECREASED 706
94 INFUSION SITE HAEMORRHAGE 703
95 DRUG INTOLERANCE 693
96 HEART RATE INCREASED 683
97 ARTHRITIS 672
98 HYPOAESTHESIA 663
99 PULMONARY EMBOLISM 663
100 NEUTROPENIA 654
101 GAIT DISTURBANCE 646
102 ILL-DEFINED DISORDER 646
103 PARAESTHESIA 643
104 LOSS OF CONSCIOUSNESS 638
105 FLUSHING 633
106 MUSCULOSKELETAL STIFFNESS 632
107 INCORRECT DRUG ADMINISTRATION RATE 626
108 DEHYDRATION 625
109 THERAPY NON-RESPONDER 619
110 THROMBOSIS 613
111 ABDOMINAL DISCOMFORT 612
112 THROMBOCYTOPENIA 586
113 HYPERHIDROSIS 583
114 JOINT SWELLING 578
115 PLATELET COUNT DECREASED 569
116 GASTROENTERITIS VIRAL 567
117 BLOOD PRESSURE DECREASED 564
118 WHEEZING 563
119 MATERNAL EXPOSURE DURING PREGNANCY 562
120 SEASONAL ALLERGY 560
121 SEIZURE 556
122 SYNCOPE 552
123 CELLULITIS 548
124 POOR VENOUS ACCESS 546
125 CEREBROVASCULAR ACCIDENT 542
126 INJECTION SITE PRURITUS 534
127 CONSTIPATION 525
128 FOETAL EXPOSURE DURING PREGNANCY 523
129 VISION BLURRED 516
130 HERPES ZOSTER 514
131 MULTIPLE ALLERGIES 508
132 NECK PAIN 507
133 LOWER RESPIRATORY TRACT INFECTION 504
134 PRODUCTIVE COUGH 502
135 HAEMOGLOBIN DECREASED 483
136 NEUROPATHY PERIPHERAL 476
137 RESPIRATORY FAILURE 475
138 LUNG DISORDER 464
139 NEOPLASM MALIGNANT 454
140 SEPTIC SHOCK 454
141 GENERAL PHYSICAL HEALTH DETERIORATION 452
142 FUNGAL INFECTION 451
143 STAPHYLOCOCCAL INFECTION 447
144 INFUSION SITE DISCHARGE 446
145 BLOOD IMMUNOGLOBULIN G DECREASED 444
146 CYSTITIS 442
147 EXPOSURE DURING PREGNANCY 441
148 RENAL FAILURE 437
149 TREATMENT FAILURE 434
150 INFUSION SITE MASS 427
151 CONFUSIONAL STATE 425
152 DEPRESSION 423
153 PHOTOPHOBIA 423
154 SINUS DISORDER 421
155 BODY TEMPERATURE INCREASED 419
156 HYPOXIA 417
157 RHEUMATOID ARTHRITIS 416
158 DEEP VEIN THROMBOSIS 412
159 MEMORY IMPAIRMENT 409
160 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 408
161 ATRIAL FIBRILLATION 403
162 OEDEMA PERIPHERAL 402
163 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 402
164 NASAL CONGESTION 401
165 PALPITATIONS 399
166 ACUTE KIDNEY INJURY 397
167 STRESS 397
168 RHINORRHOEA 396
169 RASH PRURITIC 395
170 ALOPECIA 392
171 UNEVALUABLE EVENT 392
172 EYE PAIN 391
173 NEPHROLITHIASIS 391
174 HAEMOLYSIS 390
175 CARDIAC DISORDER 388
176 ARTHROPATHY 387
177 KIDNEY INFECTION 387
178 MYOCARDIAL INFARCTION 385
179 DYSPHAGIA 382
180 ADVERSE DRUG REACTION 380
181 DERMATITIS CONTACT 380
182 WHITE BLOOD CELL COUNT DECREASED 380
183 LYMPHADENOPATHY 374
184 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 372
185 PANCYTOPENIA 370
186 CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY 367
187 CATARACT 366
188 DEVICE ISSUE 364
189 INFUSION SITE REACTION 362
190 LOCALISED INFECTION 362
191 HAEMORRHAGE 361
192 MOBILITY DECREASED 361
193 SWELLING FACE 355
194 OEDEMA 353
195 HAEMOLYTIC ANAEMIA 350
196 PLEURAL EFFUSION 346
197 RECALLED PRODUCT ADMINISTERED 346
198 NEEDLE ISSUE 344
199 VISUAL IMPAIRMENT 344
200 BURNING SENSATION 342
201 PRODUCT DISTRIBUTION ISSUE 338
202 EPISTAXIS 337
203 TINNITUS 337
204 ECZEMA 334
205 SYSTEMIC LUPUS ERYTHEMATOSUS 334
206 DIPLOPIA 333
207 HEAD DISCOMFORT 332
208 COMA 330
209 HEPATIC ENZYME INCREASED 326
210 RENAL IMPAIRMENT 324
211 BLISTER 322
212 PSORIASIS 318
213 FEELING HOT 316
214 LEUKOPENIA 314
215 LIMB INJURY 313
216 BLINDNESS 311
217 GENERALISED OEDEMA 311
218 GASTROOESOPHAGEAL REFLUX DISEASE 309
219 BACTERIAL INFECTION 308
220 INJECTION SITE BRUISING 308
221 THERAPEUTIC PRODUCT EFFECT DECREASED 308
222 DISCOMFORT 307
223 FEELING COLD 306
224 HYPOKALAEMIA 306
225 RESPIRATORY DISTRESS 305
226 LETHARGY 304
227 HAEMATURIA 303
228 PRESYNCOPE 303
229 BALANCE DISORDER 302
230 DRUG INTERACTION 300
231 DISEASE PROGRESSION 299
232 SKIN INFECTION 299
233 JOINT INJURY 297
234 TACHYPNOEA 297
235 INJECTION SITE MASS 294
236 DYSPHONIA 292
237 INFLAMMATION 292
238 PRODUCT QUALITY ISSUE 292
239 THROAT TIGHTNESS 290
240 ASCITES 289
241 PRODUCT STORAGE ERROR 289
242 ADRENAL INSUFFICIENCY 288
243 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 287
244 INFUSION SITE NODULE 286
245 INFUSION SITE RASH 284
246 CYTOMEGALOVIRUS INFECTION 283
247 RASH ERYTHEMATOUS 283
248 INFUSION SITE URTICARIA 279
249 LIMB DISCOMFORT 279
250 LIP SWELLING 278
251 MULTIPLE ORGAN DYSFUNCTION SYNDROME 278
252 DEVICE INFUSION ISSUE 277
253 THERAPY CESSATION 276
254 MYASTHENIA GRAVIS 275
255 IMMUNODEFICIENCY 274
256 PHARYNGITIS STREPTOCOCCAL 273
257 THROAT IRRITATION 269
258 DIABETES MELLITUS 268
259 CARDIO-RESPIRATORY ARREST 267
260 OCULAR DISCOMFORT 266
261 RESPIRATORY DISORDER 266
262 VERTIGO 266
263 CANDIDA INFECTION 265
264 ALTERED STATE OF CONSCIOUSNESS 264
265 RENAL DISORDER 261
266 HAEMATEMESIS 260
267 TOOTH INFECTION 259
268 SKIN EXFOLIATION 250
269 IMMUNOGLOBULINS DECREASED 249
270 INJECTION SITE REACTION 246
271 ROAD TRAFFIC ACCIDENT 244
272 COVID-19 PNEUMONIA 243
273 SYRINGE ISSUE 243
274 EYE INFECTION 241
275 HAEMORRHAGIC STROKE 241
276 PALLOR 239
277 INFUSION SITE WARMTH 238
278 INJECTION SITE HAEMORRHAGE 238
279 WEIGHT FLUCTUATION 238
280 PRODUCT AVAILABILITY ISSUE 236
281 RESPIRATORY SYNCYTIAL VIRUS INFECTION 236
282 C-REACTIVE PROTEIN INCREASED 235
283 POLYARTHRITIS 235
284 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 233
285 DIVERTICULITIS 231
286 UNDERDOSE 231
287 TRANSIENT ISCHAEMIC ATTACK 225
288 CARDIAC ARREST 224
289 CLOSTRIDIUM DIFFICILE INFECTION 224
290 FLUID RETENTION 224
291 BLOOD PRESSURE ABNORMAL 223
292 BONE PAIN 223
293 MENINGITIS 222
294 PRODUCT DOSE OMISSION IN ERROR 222
295 INFUSION SITE INDURATION 221
296 PREMATURE BABY 221
297 BRAIN FOG 219
298 HEAD INJURY 216
299 INFUSION SITE DISCOMFORT 214
300 OBESITY 214
301 AMAUROSIS FUGAX 213
302 FEBRILE NEUTROPENIA 212
303 INCORRECT PRODUCT ADMINISTRATION DURATION 211
304 ANGIOEDEMA 210
305 AUTOIMMUNE DISORDER 210
306 FIBROMYALGIA 210
307 BLOOD CREATININE INCREASED 207
308 INABILITY TO AFFORD MEDICATION 206
309 PSEUDOMONAS INFECTION 204
310 THERAPY CHANGE 204
311 MUSCULOSKELETAL PAIN 203
312 SWOLLEN TONGUE 203
313 URINARY TRACT DISORDER 203
314 HYPOGAMMAGLOBULINAEMIA 202
315 CARDIAC FAILURE 201
316 SLEEP DISORDER 201
317 DYSPEPSIA 200
318 HEART RATE DECREASED 200
319 NEURALGIA 199
320 OSTEOPOROSIS 198
321 DRY MOUTH 196
322 SURGERY 196
323 TREATMENT NONCOMPLIANCE 196
324 BRONCHIECTASIS 195
325 GASTROINTESTINAL INFECTION 195
326 COLITIS 194
327 RASH MACULAR 194
328 ABORTION SPONTANEOUS 193
329 INTERSTITIAL LUNG DISEASE 192
330 SKIN LACERATION 192
331 SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT 190
332 POST PROCEDURAL COMPLICATION 188
333 RESPIRATORY RATE INCREASED 188
334 GASTROINTESTINAL HAEMORRHAGE 187
335 CARDIAC FAILURE CONGESTIVE 186
336 INFUSION SITE IRRITATION 185
337 SKIN DISCOLOURATION 185
338 HYPOCALCAEMIA 184
339 EAR PAIN 183
340 SPEECH DISORDER 183
341 CONTRAINDICATED PRODUCT ADMINISTERED 182
342 DRY SKIN 182
343 SCAR 182
344 SYNOVITIS 182
345 BLOOD GLUCOSE INCREASED 181
346 BRADYCARDIA 181
347 PNEUMONIA ASPIRATION 181
348 SINUS CONGESTION 181
349 PHARYNGITIS 180
350 PULMONARY FIBROSIS 180
351 URINE OUTPUT DECREASED 180
352 FOOT FRACTURE 179
353 PNEUMONIA BACTERIAL 179
354 PREGNANCY 178
355 WOUND 177
356 LUNG INFECTION 175
357 PRODUCT SUPPLY ISSUE 175
358 HOT FLUSH 174
359 PRODUCT USE COMPLAINT 173
360 PULMONARY OEDEMA 172
361 WHITE BLOOD CELL COUNT INCREASED 172
362 NODULE 171
363 HIP FRACTURE 170
364 HYPERSOMNIA 170
365 CONJUNCTIVITIS 169
366 LIVER DISORDER 168
367 TENDERNESS 168
368 GAIT INABILITY 165
369 MYELOSUPPRESSION 165
370 ASPARTATE AMINOTRANSFERASE INCREASED 163
371 CHRONIC SINUSITIS 162
372 CYTOMEGALOVIRUS INFECTION REACTIVATION 162
373 LIQUID PRODUCT PHYSICAL ISSUE 162
374 AGITATION 161
375 CYANOSIS 161
376 ANAPHYLACTIC SHOCK 160
377 PANCREATITIS 160
378 ALANINE AMINOTRANSFERASE INCREASED 159
379 LYMPHOMA 159
380 JOINT DESTRUCTION 158
381 PARAESTHESIA ORAL 157
382 CYTOMEGALOVIRUS VIRAEMIA 155
383 DEPRESSED MOOD 153
384 NEUTROPHIL COUNT DECREASED 153
385 MUSCULOSKELETAL DISCOMFORT 152
386 PLASMA CELL MYELOMA 152
387 IMMUNE THROMBOCYTOPENIA 151
388 RIB FRACTURE 151
389 STOMATITIS 151
390 RESPIRATORY TRACT CONGESTION 150
391 DYSARTHRIA 148
392 HAEMATOMA 148
393 NERVOUSNESS 148
394 DRUG RESISTANCE 147
395 OSTEOARTHRITIS 146
396 PROCEDURAL PAIN 145
397 SKIN LESION 144
398 HEPATOTOXICITY 143
399 INJECTION SITE EXTRAVASATION 142
400 TRANSPLANT REJECTION 142
401 APHASIA 141
402 BLOOD IRON DECREASED 141
403 BREAST CANCER 141
404 BRONCHOSPASM 141
405 HYPONATRAEMIA 141
406 STREPTOCOCCAL INFECTION 141
407 DYSPNOEA EXERTIONAL 140
408 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 140
409 BLOOD IMMUNOGLOBULIN G INCREASED 139
410 EPSTEIN-BARR VIRUS INFECTION 139
411 IRRITABILITY 139
412 LARYNGITIS 139
413 OSTEOMYELITIS 139
414 SNEEZING 139
415 SKIN CANCER 138
416 ARRHYTHMIA 137
417 INFUSION SITE SCAR 137
418 WHEELCHAIR USER 137
419 RASH PAPULAR 135
420 RED BLOOD CELL SEDIMENTATION RATE INCREASED 135
421 DYSURIA 134
422 NEPHROPATHY TOXIC 134
423 SKIN REACTION 134
424 SPINAL FRACTURE 134
425 CYTOKINE RELEASE SYNDROME 133
426 MENTAL DISORDER 133
427 ANTIBODY TEST POSITIVE 132
428 DRUG DOSE OMISSION 132
429 DRUG TOLERANCE 132
430 EYE SWELLING 131
431 OBSTRUCTION 131
432 PHARYNGEAL SWELLING 131
433 AMNESIA 130
434 CHROMATURIA 130
435 ESCHERICHIA INFECTION 130
436 POLLAKIURIA 130
437 JOINT STIFFNESS 129
438 PRODUCT ADMINISTRATION ERROR 129
439 SPLENOMEGALY 129
440 HERNIA 128
441 INJECTION SITE RASH 128
442 INJECTION SITE URTICARIA 128
443 MASS 128
444 ASPERGILLUS INFECTION 127
445 COLD SWEAT 127
446 SKIN DISORDER 127
447 ARTHROPOD BITE 126
448 BLOOD POTASSIUM DECREASED 126
449 COGNITIVE DISORDER 126
450 DRY EYE 126
451 RHINITIS 126
452 CORONARY ARTERY DISEASE 125
453 DISEASE RECURRENCE 125
454 INTESTINAL OBSTRUCTION 125
455 ADVERSE EVENT 124
456 BACTERAEMIA 124
457 FOOD ALLERGY 124
458 TOOTH ABSCESS 124
459 HEPATIC FUNCTION ABNORMAL 123
460 PERICARDIAL EFFUSION 123
461 BACK DISORDER 122
462 FLANK PAIN 122
463 LIVER FUNCTION TEST ABNORMAL 122
464 PULMONARY MASS 122
465 ADMINISTRATION SITE SWELLING 121
466 HAEMATOCHEZIA 121
467 POOR QUALITY SLEEP 121
468 PREMATURE DELIVERY 121
469 FEBRILE NONHAEMOLYTIC TRANSFUSION REACTION 120
470 HEPATITIS B CORE ANTIBODY POSITIVE 120
471 POST PROCEDURAL INFECTION 120
472 RASH GENERALISED 120
473 BLOOD PRESSURE SYSTOLIC INCREASED 119
474 BONE DENSITY DECREASED 119
475 C-REACTIVE PROTEIN ABNORMAL 119
476 IRRITABLE BOWEL SYNDROME 119
477 UPPER LIMB FRACTURE 119
478 ANAPHYLACTOID REACTION 118
479 EPILEPSY 118
480 NIGHT SWEATS 118
481 INJECTION SITE INDURATION 117
482 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 116
483 LYMPHOPENIA 116
484 ORAL HERPES 116
485 SHOCK 116
486 DISTURBANCE IN ATTENTION 115
487 IMPAIRED HEALING 115
488 ORAL CANDIDIASIS 115
489 RASH MACULO-PAPULAR 115
490 OBSTRUCTIVE AIRWAYS DISORDER 114
491 RHINOVIRUS INFECTION 113
492 SKIN IRRITATION 112
493 SKIN ULCER 112
494 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 111
495 ENCEPHALITIS 111
496 NO THERAPEUTIC RESPONSE 111
497 INFUSION SITE DISCOLOURATION 110
498 INFUSION SITE OEDEMA 110
499 PETECHIAE 110
500 PRODUCT DOSE OMISSION 110
501 PRODUCT PRESCRIBING ISSUE 110
502 RESTLESSNESS 110
503 HAEMOPTYSIS 109
504 OVERDOSE 109
505 PNEUMOCYSTIS JIROVECII PNEUMONIA 109
506 RHEUMATOID FACTOR POSITIVE 109
507 THERAPY PARTIAL RESPONDER 109
508 ACUTE RESPIRATORY FAILURE 108
509 BK VIRUS INFECTION 108
510 DEVICE RELATED INFECTION 108
511 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 108
512 NERVOUS SYSTEM DISORDER 108
513 TOXIC EPIDERMAL NECROLYSIS 108
514 BLOOD SODIUM DECREASED 107
515 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 107
516 COAGULOPATHY 106
517 LIGAMENT SPRAIN 106
518 ADMINISTRATION SITE PAIN 105
519 BLOOD PRESSURE FLUCTUATION 105
520 CEREBRAL HAEMORRHAGE 105
521 JUVENILE IDIOPATHIC ARTHRITIS 105
522 LYME DISEASE 105
523 MOVEMENT DISORDER 105
524 SCIATICA 105
525 SPUTUM DISCOLOURED 105
526 THROMBOTIC MICROANGIOPATHY 105
527 CROHN^S DISEASE 104
528 DEVICE LEAKAGE 104
529 FLATULENCE 104
530 FOETAL GROWTH RESTRICTION 104
531 FOOT DEFORMITY 104
532 HEREDITARY ANGIOEDEMA 104
533 IMPAIRED GASTRIC EMPTYING 104
534 THYROID DISORDER 104
535 BLOOD IMMUNOGLOBULIN A DECREASED 103
536 CHRONIC LYMPHOCYTIC LEUKAEMIA 103
537 DISORIENTATION 103
538 IMMUNE SYSTEM DISORDER 103
539 CYTOPENIA 102
540 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 102
541 URINARY RETENTION 102
542 ACUTE RESPIRATORY DISTRESS SYNDROME 101
543 ADVERSE REACTION 101
544 BLOOD BILIRUBIN INCREASED 101
545 BLOOD URINE PRESENT 101
546 CONCUSSION 101
547 ENCEPHALOPATHY 101
548 FOOD POISONING 101
549 HEPATIC FAILURE 101
550 HEPATITIS B 101
551 INJECTION SITE DISCHARGE 101
552 PULMONARY THROMBOSIS 101
553 THERAPEUTIC RESPONSE SHORTENED 101
554 MUSCLE TWITCHING 100
555 MUSCULOSKELETAL CHEST PAIN 100
556 TRANSFUSION REACTION 100
557 EYE IRRITATION 99
558 GASTRITIS 99
559 JAUNDICE 99
560 LOWER LIMB FRACTURE 99
561 PEMPHIGUS 99
562 CYSTITIS HAEMORRHAGIC 98
563 LEUKAEMIA 98
564 WOUND INFECTION 98
565 EYE DISORDER 97
566 FEAR OF INJECTION 97
567 INTENTIONAL DOSE OMISSION 97
568 OCULAR HYPERAEMIA 97
569 SARS-COV-2 TEST POSITIVE 97
570 SUSPECTED OFF LABEL USE 97
571 GLOSSODYNIA 96
572 HYPOAESTHESIA ORAL 96
573 PNEUMOTHORAX 96
574 VASCULITIS 96
575 CONVULSION 95
576 DEVICE BREAKAGE 95
577 SJOGREN^S SYNDROME 95
578 UNRESPONSIVE TO STIMULI 95
579 INJURY 94
580 PULMONARY TOXICITY 94
581 RED BLOOD CELL COUNT DECREASED 94
582 ACUTE MYOCARDIAL INFARCTION 93
583 CRYING 93
584 GASTRIC ULCER 93
585 HAND DEFORMITY 93
586 INJECTION SITE DISCOMFORT 93
587 PRURITUS GENERALISED 93
588 BLOOD GLUCOSE DECREASED 92
589 DISSEMINATED INTRAVASCULAR COAGULATION 92
590 PAIN IN JAW 92
591 VASCULAR DEVICE INFECTION 92
592 APHONIA 91
593 BLOOD CREATINE PHOSPHOKINASE INCREASED 91
594 COOMBS DIRECT TEST POSITIVE 91
595 GUILLAIN-BARRE SYNDROME 91
596 HYPERVOLAEMIA 91
597 PANIC ATTACK 91
598 AUTOIMMUNE HAEMOLYTIC ANAEMIA 90
599 DYSSTASIA 90
600 GASTROINTESTINAL TOXICITY 90
601 INJECTION SITE WARMTH 90
602 POSTOPERATIVE WOUND INFECTION 90
603 SLEEP APNOEA SYNDROME 90
604 TOOTH DISORDER 90
605 TOXICITY TO VARIOUS AGENTS 90
606 UPPER-AIRWAY COUGH SYNDROME 90
607 URINARY INCONTINENCE 90
608 PRODUCT LEAKAGE 89
609 HYPOACUSIS 88
610 KNEE ARTHROPLASTY 88
611 PHOTOSENSITIVITY REACTION 88
612 POST-ACUTE COVID-19 SYNDROME 88
613 PSORIATIC ARTHROPATHY 88
614 RENAL FAILURE ACUTE 88
615 THERAPEUTIC RESPONSE DECREASED 88
616 TRANSFUSION-RELATED ACUTE LUNG INJURY 88
617 ADMINISTRATION SITE ERYTHEMA 87
618 ANKLE FRACTURE 87
619 BODY TEMPERATURE DECREASED 87
620 DEPRESSED LEVEL OF CONSCIOUSNESS 87
621 HEPATITIS B SURFACE ANTIBODY POSITIVE 87
622 INFUSION SITE VESICLES 87
623 MENTAL IMPAIRMENT 87
624 RECTAL HAEMORRHAGE 87
625 SPINAL PAIN 87
626 WRIST FRACTURE 87
627 BEDRIDDEN 86
628 BRONCHOPULMONARY ASPERGILLOSIS 86
629 INFUSION SITE INFECTION 86
630 SPINAL OPERATION 86
631 BODY HEIGHT BELOW NORMAL 85
632 GOUT 85
633 HEMIPARESIS 85
634 HUMAN ANTICHIMERIC ANTIBODY POSITIVE 85
635 PERIPHERAL COLDNESS 85
636 VEIN DISORDER 85
637 ABSCESS 84
638 GASTROENTERITIS 84
639 MEDICATION ERROR 84
640 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 84
641 ROTATOR CUFF SYNDROME 84
642 CYST 83
643 EYELID PTOSIS 83
644 HYPERGLYCAEMIA 83
645 INTERVERTEBRAL DISC PROTRUSION 83
646 PULMONARY HYPERTENSION 83
647 BLOOD LACTATE DEHYDROGENASE INCREASED 82
648 CHOLELITHIASIS 82
649 MULTIPLE SCLEROSIS 82
650 PRODUCT TEMPERATURE EXCURSION ISSUE 82
651 SECRETION DISCHARGE 82
652 ASPIRATION 81
653 DELIRIUM 81
654 HEPATITIS 81
655 THERAPEUTIC RESPONSE UNEXPECTED 81
656 TOOTHACHE 81
657 BLOOD TEST ABNORMAL 80
658 DERMATOMYOSITIS 80
659 BACK INJURY 79
660 BLOOD IMMUNOGLOBULIN M DECREASED 79
661 FULL BLOOD COUNT ABNORMAL 79
662 IMPAIRED WORK ABILITY 79
663 INJECTION SITE IRRITATION 79
664 INSPIRATORY CAPACITY DECREASED 79
665 LABORATORY TEST ABNORMAL 79
666 RENAL PAIN 79
667 RESPIRATORY TRACT INFECTION VIRAL 79
668 RESTLESS LEGS SYNDROME 79
669 ATAXIA 78
670 BRAIN OEDEMA 78
671 HELICOBACTER INFECTION 78
672 LYMPHOCYTE COUNT DECREASED 78
673 PARANASAL SINUS DISCOMFORT 78
674 PNEUMONIA FUNGAL 78
675 WALKING AID USER 78
676 AGRANULOCYTOSIS 77
677 BLADDER DISORDER 77
678 CIRCULATORY COLLAPSE 77
679 COLITIS ULCERATIVE 77
680 DYSGEUSIA 77
681 ENCEPHALITIS CYTOMEGALOVIRUS 77
682 HEPATOMEGALY 77
683 MENTAL STATUS CHANGES 77
684 DEMENTIA 76
685 DERMATITIS 76
686 FACIAL PAIN 76
687 HYPERTHERMIA 76
688 INJECTION SITE NODULE 76
689 LUNG NEOPLASM MALIGNANT 76
690 ULCER 76
691 DRUG EFFECT DECREASED 75
692 EYE PRURITUS 75
693 LIVER FUNCTION TEST INCREASED 75
694 NOROVIRUS INFECTION 75
695 SENSITIVE SKIN 75
696 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 75
697 CARPAL TUNNEL SYNDROME 74
698 EATING DISORDER 74
699 FEEDING DISORDER 74
700 GRAFT VERSUS HOST DISEASE 74
701 JOINT EFFUSION 74
702 LACRIMATION INCREASED 74
703 MYOSITIS 74
704 ATYPICAL PNEUMONIA 73
705 DEAFNESS 73
706 HYPOGLYCAEMIA 73
707 MUSCLE STRAIN 73
708 MUSCLE TIGHTNESS 73
709 OROPHARYNGEAL DISCOMFORT 73
710 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 73
711 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 73
712 SKIN ABRASION 73
713 TASTE DISORDER 73
714 UROSEPSIS 73
715 AUTOIMMUNE THYROIDITIS 72
716 BLOOD MAGNESIUM DECREASED 72
717 GALLBLADDER DISORDER 72
718 HYPOPHAGIA 72
719 DRUG EXPOSURE DURING PREGNANCY 71
720 HAEMATOLOGICAL INFECTION 71
721 HALLUCINATION 71
722 IMMUNE-MEDIATED MYOSITIS 71
723 MOUTH ULCERATION 71
724 SKIN BURNING SENSATION 71
725 STATUS EPILEPTICUS 71
726 DERMATITIS ALLERGIC 70
727 DEVICE OCCLUSION 70
728 DRUG ERUPTION 70
729 DYSKINESIA 70
730 FOETAL DEATH 70
731 MALIGNANT NEOPLASM PROGRESSION 70
732 METABOLIC ACIDOSIS 70
733 ORAL INFECTION 70
734 ORAL PAIN 70
735 SECONDARY IMMUNODEFICIENCY 70
736 BODY HEIGHT DECREASED 69
737 CHRONIC KIDNEY DISEASE 69
738 DEVICE DIFFICULT TO USE 69
739 FINE MOTOR SKILL DYSFUNCTION 69
740 GASTRIC INFECTION 69
741 HAEMORRHAGE INTRACRANIAL 69
742 HEART RATE IRREGULAR 69
743 HYPOALBUMINAEMIA 69
744 LIVEDO RETICULARIS 69
745 PULMONARY CONGESTION 69
746 QUALITY OF LIFE DECREASED 69
747 SKIN MASS 69
748 SUSPECTED COVID-19 69
749 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 68
750 EPSTEIN-BARR VIRAEMIA 68
751 FOOT OPERATION 68
752 IMMUNOSUPPRESSION 68
753 SUICIDAL IDEATION 68
754 EMOTIONAL DISTRESS 67
755 GAMMA-GLUTAMYLTRANSFERASE INCREASED 67
756 HEPATIC CIRRHOSIS 67
757 ISCHAEMIC STROKE 67
758 LYMPHADENITIS 67
759 PNEUMONITIS 67
760 TRANSAMINASES INCREASED 67
761 DEVICE MALFUNCTION 66
762 HYPERTENSIVE CRISIS 66
763 IMMUNISATION REACTION 66
764 PRODUCT SUBSTITUTION ISSUE 66
765 SCAB 66
766 BASAL CELL CARCINOMA 65
767 BLOOD PRESSURE SYSTOLIC DECREASED 65
768 COMPLICATION ASSOCIATED WITH DEVICE 65
769 GENERALISED TONIC-CLONIC SEIZURE 65
770 HAND FRACTURE 65
771 HYPOTHYROIDISM 65
772 IMPAIRED QUALITY OF LIFE 65
773 LEUKOCYTOSIS 65
774 NERVE COMPRESSION 65
775 PERICARDITIS 65
776 PHARYNGEAL OEDEMA 65
777 POLYNEUROPATHY 65
778 RHESUS ANTIBODIES POSITIVE 65
779 ACUTE PULMONARY OEDEMA 64
780 ALLERGY TO IMMUNOGLOBULIN THERAPY 64
781 BURSITIS 64
782 FEELING JITTERY 64
783 HEPATIC STEATOSIS 64
784 MYASTHENIA GRAVIS CRISIS 64
785 OSTEONECROSIS 64
786 REBOUND EFFECT 64
787 SINUSITIS BACTERIAL 64
788 TYPE 2 DIABETES MELLITUS 64
789 ADENOVIRUS INFECTION 63
790 FEMUR FRACTURE 63
791 INJECTION SITE OEDEMA 63
792 LIVER INJURY 63
793 MULTIPLE-DRUG RESISTANCE 63
794 PARALYSIS 63
795 PLEURISY 63
796 VEIN RUPTURE 63
797 ADMINISTRATION SITE EXTRAVASATION 62
798 CARDIOGENIC SHOCK 62
799 COOMBS POSITIVE HAEMOLYTIC ANAEMIA 62
800 DRUG-INDUCED LIVER INJURY 62
801 ELECTROLYTE IMBALANCE 62
802 BLOOD CHOLESTEROL INCREASED 61
803 CHOKING 61
804 ENTEROCOCCAL INFECTION 61
805 INFUSION SITE INFLAMMATION 61
806 MAST CELL ACTIVATION SYNDROME 61
807 PRESCRIBED UNDERDOSE 61
808 BLOOD PRESSURE DIASTOLIC DECREASED 60
809 CEREBRAL INFARCTION 60
810 GASTRIC DISORDER 60
811 GLOMERULAR FILTRATION RATE DECREASED 60
812 MALABSORPTION FROM INJECTION SITE 60
813 MULTI-ORGAN FAILURE 60
814 PLATELET COUNT INCREASED 60
815 TREATMENT DELAYED 60
816 DRY THROAT 59
817 FRUSTRATION TOLERANCE DECREASED 59
818 HORDEOLUM 59
819 NERVE INJURY 59
820 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 59
821 ACNE 58
822 ACUTE HEPATIC FAILURE 58
823 HAEMATOCRIT DECREASED 58
824 HIATUS HERNIA 58
825 PARTIAL SEIZURES 58
826 SERUM FERRITIN INCREASED 58
827 TOOTH FRACTURE 58
828 ABDOMINAL PAIN LOWER 57
829 AGGRESSION 57
830 ANTINUCLEAR ANTIBODY POSITIVE 57
831 ARTHRITIS INFECTIVE 57
832 DECREASED IMMUNE RESPONSIVENESS 57
833 DRUG EFFECT LESS THAN EXPECTED 57
834 FULL BLOOD COUNT DECREASED 57
835 GLAUCOMA 57
836 GRIP STRENGTH DECREASED 57
837 PNEUMONIA VIRAL 57
838 ACCIDENT 56
839 ACCIDENTAL EXPOSURE TO PRODUCT 56
840 ANGINA PECTORIS 56
841 BLOOD ALKALINE PHOSPHATASE INCREASED 56
842 HYPERKALAEMIA 56
843 IMMUNODEFICIENCY COMMON VARIABLE 56
844 INJECTION SITE INFECTION 56
845 MISLEADING LABORATORY TEST RESULT 56
846 PNEUMONIA PSEUDOMONAL 56
847 RETCHING 56
848 SPUTUM PURULENT 56
849 TOXIC SKIN ERUPTION 56
850 DISABILITY 55
851 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 55
852 FACIAL PARALYSIS 55
853 PERONEAL NERVE PALSY 55
854 RALES 55
855 RASH VESICULAR 55
856 SERUM SICKNESS 55
857 STIFF PERSON SYNDROME 55
858 VIRAL UPPER RESPIRATORY TRACT INFECTION 55
859 ADMINISTRATION SITE REACTION 54
860 BLOOD IMMUNOGLOBULIN G ABNORMAL 54
861 BLOOD LACTIC ACID INCREASED 54
862 COVID-19 IMMUNISATION 54
863 ELECTRIC SHOCK SENSATION 54
864 FOLLICULITIS 54
865 JOINT DISLOCATION 54
866 KLEBSIELLA INFECTION 54
867 PNEUMONIA CYTOMEGALOVIRAL 54
868 STEVENS-JOHNSON SYNDROME 54
869 EAR DISCOMFORT 53
870 ENCEPHALITIS AUTOIMMUNE 53
871 HEART RATE ABNORMAL 53
872 INFECTIOUS MONONUCLEOSIS 53
873 NEOPLASM 53
874 SENSORY DISTURBANCE 53
875 SPINAL DISORDER 53
876 ANIMAL BITE 52
877 EOSINOPHILIA 52
878 INTERNAL HAEMORRHAGE 52
879 LYMPHOEDEMA 52
880 MUCOSAL INFLAMMATION 52
881 SINUS HEADACHE 52
882 SKIN FISSURES 52
883 SLUGGISHNESS 52
884 APPENDICITIS 51
885 ATELECTASIS 51
886 CARDIOVASCULAR DISORDER 51
887 CREPITATIONS 51
888 FREQUENT BOWEL MOVEMENTS 51
889 INCREASED TENDENCY TO BRUISE 51
890 INTENTIONAL PRODUCT MISUSE 51
891 PELVIC FRACTURE 51
892 PRODUCT ADMINISTRATION INTERRUPTED 51
893 PURPURA 51
894 VENTRICULAR TACHYCARDIA 51
895 BLINDNESS UNILATERAL 50
896 BLOOD GLUCOSE ABNORMAL 50
897 BRAIN INJURY 50
898 FACE OEDEMA 50
899 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 50
900 HAEMORRHOIDS 50
901 HYPERAESTHESIA 50
902 MYELODYSPLASTIC SYNDROME 50
903 PAPULE 50
904 PHLEBITIS 50
905 RESPIRATORY ARREST 50
906 TRANSFUSION-RELATED CIRCULATORY OVERLOAD 50
907 CENTRAL NERVOUS SYSTEM LESION 49
908 ENERGY INCREASED 49
909 EXPIRED PRODUCT ADMINISTERED 49
910 FUNGAL SKIN INFECTION 49
911 GASTROINTESTINAL PAIN 49
912 HYPOTHERMIA 49
913 KIDNEY TRANSPLANT REJECTION 49
914 MENINGITIS VIRAL 49
915 MOTOR DYSFUNCTION 49
916 MOUTH SWELLING 49
917 OXYGEN SATURATION ABNORMAL 49
918 PRODUCT PRESCRIBING ERROR 49
919 PYELONEPHRITIS 49
920 SKIN WARM 49
921 SQUAMOUS CELL CARCINOMA 49
922 ANGER 48
923 BODY TEMPERATURE ABNORMAL 48
924 CARDIOMYOPATHY 48
925 GINGIVAL BLEEDING 48
926 HEPATOCELLULAR INJURY 48
927 HIP ARTHROPLASTY 48
928 INTRACRANIAL PRESSURE INCREASED 48
929 MYOCARDITIS 48
930 PLATELET COUNT ABNORMAL 48
931 SINUS OPERATION 48
932 TENDONITIS 48
933 THERMAL BURN 48
934 ACUTE MYELOID LEUKAEMIA 47
935 CLOSTRIDIUM DIFFICILE COLITIS 47
936 EAR DISORDER 47
937 FAECES DISCOLOURED 47
938 MENISCUS INJURY 47
939 PRESCRIBED OVERDOSE 47
940 PRODUCT PHYSICAL ISSUE 47
941 PROSTATE CANCER 47
942 CAESAREAN SECTION 46
943 CHOLECYSTECTOMY 46
944 DRUG SPECIFIC ANTIBODY 46
945 IMMUNOGLOBULINS ABNORMAL 46
946 INFUSION SITE HAEMATOMA 46
947 INJECTION SITE SCAR 46
948 INJURY ASSOCIATED WITH DEVICE 46
949 LOCAL REACTION 46
950 MALIGNANT MELANOMA 46
951 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 46
952 PRODUCT PREPARATION ISSUE 46
953 TROPONIN INCREASED 46
954 ANKLE ARTHROPLASTY 45
955 AUTONOMIC NERVOUS SYSTEM IMBALANCE 45
956 BLOOD UREA INCREASED 45
957 COLON CANCER 45
958 DERMATITIS EXFOLIATIVE GENERALISED 45
959 DRUG DEPENDENCE 45
960 EMBOLISM 45
961 EMOTIONAL DISORDER 45
962 INFECTED BITE 45
963 MYASTHENIC SYNDROME 45
964 NEOPLASM PROGRESSION 45
965 NON-HODGKIN^S LYMPHOMA 45
966 SMALL INTESTINAL OBSTRUCTION 45
967 STAPHYLOCOCCAL BACTERAEMIA 45
968 SUPRAVENTRICULAR TACHYCARDIA 45
969 THIRST 45
970 ELECTROCARDIOGRAM QT PROLONGED 44
971 FEELING OF BODY TEMPERATURE CHANGE 44
972 GINGIVITIS 44
973 HYPERBILIRUBINAEMIA 44
974 LOW BIRTH WEIGHT BABY 44
975 LUNG INFILTRATION 44
976 MELAENA 44
977 OTITIS MEDIA 44
978 PARANASAL SINUS HYPERSECRETION 44
979 POLYP 44
980 VARICELLA ZOSTER VIRUS INFECTION 44
981 ANTI A ANTIBODY POSITIVE 43
982 BONE MARROW FAILURE 43
983 ERUCTATION 43
984 GESTATIONAL DIABETES 43
985 HERPES SIMPLEX 43
986 HYPERTRANSAMINASAEMIA 43
987 MENINGISM 43
988 PRODUCT CONTAINER ISSUE 43
989 AGEUSIA 42
990 ANAL INCONTINENCE 42
991 ATRIAL FLUTTER 42
992 CROUP INFECTIOUS 42
993 CUSHINGOID 42
994 DERMATITIS BULLOUS 42
995 HEPATITIS C 42
996 HYPOKINESIA 42
997 IMMUNOGLOBULINS INCREASED 42
998 INJECTION SITE DISCOLOURATION 42
999 INJECTION SITE VESICLES 42